Reaction Details Report a problem with these data
Target
Monoglyceride lipase
Ligand
BDBM483821
Substrate
n/a
Meas. Tech.
In Vitro Competitive Activity-Based Protein Profiling
IC50
<100±n/a nM
Citation
 Grice, CA; Wiener, JJ; Weber, OD; Duncan, KK Pyrazole MAGL inhibitors US Patent  US10927105 Publication Date 2/23/2021 
Target
Name:
Monoglyceride lipase
Synonyms:
HU-K5 | Lysophospholipase homolog | Lysophospholipase-like | MAGL | MGL | MGLL | MGLL_HUMAN
Type:
Hydrolase
Mol. Mass.:
33264.56
Organism:
Homo sapiens (Human)
Description:
Human recombinant MGL (Cayman Chemical, cat# 10008354).
Residue:
303
Sequence:
MPEESSPRRTPQSIPYQDLPHLVNADGQYLFCRYWKPTGTPKALIFVSHGAGEHSGRYEELARMLMGLDLLVFAHDHVGHGQSEGERMVVSDFHVFVRDVLQHVDSMQKDYPGLPVFLLGHSMGGAIAILTAAERPGHFAGMVLISPLVLANPESATTFKVLAAKVLNLVLPNLSLGPIDSSVLSRNKTEVDIYNSDPLICRAGLKVCFGIQLLNAVSRVERALPKLTVPFLLLQGSADRLCDSKGAYLLMELAKSQDKTLKIYEGAYHVLHKELPEVTNSVFHEINMWVSQRTATAGTASPP
  
Inhibitor
Name:
BDBM483821
Synonyms:
1-(4-(3-(4- chlorophenoxy)-5- fluorobenzyl)- piperazine-1- carbonyl)-4- methyl-1H- pyrazole-3- carboxylic acid | US10927105, Ex 346 | US11655217, Example 346
Type:
Small organic molecule
Emp. Form.:
C23H22ClFN4O4
Mol. Mass.:
472.897
SMILES:
Cc1cn(nc1C(O)=O)C(=O)N1CCN(Cc2cc(F)cc(Oc3ccc(Cl)cc3)c2)CC1
Structure:
Search PDB for entries with ligand similarity: